✦ LIBER ✦

128 Preliminary results of a phase II study with Taxol® (paclitaxel) and cisplatin in advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Pérol, M.; Souquet, P.J.; Riou, R.; Fournel, P.; Dussopt, C.; Vuillermoz, S.; Bombaron, P.; Tete, L.; Pellae-Cosset, B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study with Taxol® (paclitaxel)

✍ Douillard, J.Y; Lerouge, D; Monnier, A; Sun, X.S; Haller, M.A; Assouline, D; Gra 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 218 KB

A phase II study of a modified cisplatin

✍ Gonzalez-Martin, A; Garcia-Lopez, JL; Crespo, C; Lastra, E; Pedraza, M; Rios, A; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Phase II study of paclitaxel (Genaxol®)

✍ Chen, Chih-Hung; Chang, Wen-Cheng; Lin, Meng-Chin; Hsu, Jen-Wen; Chao, Tsu-Yi; T 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Oral etoposide preceding cisplatin in ad

✍ Focan, C.; Vandermoten, G.; Boossy, J.; Schallier, D. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 571 KB

Paclitaxel (T) and carboplatin (C): A ph

✍ Fírvida, J.L; Amenedo, M; Salgado, M; Gonzalez-Quintas, A; Garcia Mata, J; Losad 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

78 A phase II study of paclitaxel (Taxol

✍ Thongprasert, Sumitra 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 159 KB